<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: This article represents the first report in the ophthalmology literature of an association between <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> (PTC) and recombinant human growth hormone (rhGH) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Noncomparative case series </plain></SENT>
<SENT sid="2" pm="."><plain>PARTICIPANTS: Three children receiving rhGH for <z:hpo ids='HP_0004322'>short stature</z:hpo> with <z:e sem="disease" ids="C0041408" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Turner syndrome</z:e>, <z:e sem="disease" ids="C0265275" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Jeune syndrome</z:e>, or <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Children underwent full ocular examination </plain></SENT>
<SENT sid="4" pm="."><plain>After <z:hpo ids='HP_0001085'>papilledema</z:hpo> was identified, patients underwent lumbar puncture and imaging with either magnetic resonance imaging or computerized tomography </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment was under the guidance of the primary physician or neurosurgeon </plain></SENT>
<SENT sid="6" pm="."><plain>The rhGH was discontinued in <z:hpo ids='HP_0000001'>all</z:hpo> children </plain></SENT>
<SENT sid="7" pm="."><plain>MAIN OUTCOME MEASURES: Visual acuity and evaluation of the optic nerve for resolution of <z:hpo ids='HP_0001085'>papilledema</z:hpo> were followed at each examination </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: In <z:hpo ids='HP_0000001'>all</z:hpo> three cases, <z:hpo ids='HP_0001085'>papilledema</z:hpo> resolved with the cessation of rhGH, and treatment with <z:chebi fb="0" ids="27690">acetazolamide</z:chebi> or <z:chebi fb="0" ids="8382">prednisone</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Visual acuity was unchanged in case 1, decreased by two to three lines in case 2, and was inconsistent in case 3 </plain></SENT>
<SENT sid="10" pm="."><plain>One child (case 2) required a ventriculoperitoneal shunt for persistent elevation of intracranial pressure </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: There appears to be a causal relationship between the initiation of rhGH with the development of PTC </plain></SENT>
<SENT sid="12" pm="."><plain>Children should have a complete ophthalmic evaluation if they report <z:hpo ids='HP_0002315'>headache</z:hpo> or visual disturbances </plain></SENT>
<SENT sid="13" pm="."><plain>Baseline examination with routine follow-up should be instituted when children cannot adequately communicate </plain></SENT>
</text></document>